Recent extremely meaningful negative changes in investment behavior have impacted Globus Medical Inc (NYSE: GMED): the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative upside/downside volume developed.
Globus Medical Inc (NYSE: GMED) has recently experienced slight negative changes in fundamentals: significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, GMED is expected to continue to be a modest Value Builder.
Globus Medical has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Globus Medical has a good Appreciation Score of 76 but a slightly negative Power Rating of 40, producing the Neutral Value Trend Rating.
Recent Price Action
Globus Medical Inc (NYSE: GMED) stock declined slightly by -0.2% on 3/22/24. The stock closed at $52.02. However, this decline was accompanied by below average trading volume at 75% of normal. The stock has been weak relative to the market over the last nine months but is unchanged during the last week.
Be the first to comment